BSX vs. CI: Boston Scientific vs. Cigna Stock Comparison
How do Boston Scientific (BSX) and Cigna (CI) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Boston Scientific (BSX) and Cigna (CI) both fall under the Health Care Equipment & Services industry group, but BSX is classified in Health Care Equipment & Supplies while CI is classified in Health Care Providers & Services.
| Profile Item | BSX | CI |
|---|---|---|
| Name | Boston Scientific Corp. | The Cigna Group |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Equipment | Health Care Services |
| Market Capitalization | 61.96 billion USD | 77.36 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | May 19, 1992 | March 31, 1982 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BSX | CI |
|---|---|---|
| Total Return (1Y) | -55.98% | 13.95% |
| Total Return (3Y, Annualized) | -5.05% | 2.65% |
| Total Return (5Y, Annualized) | 0.57% | 8.40% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BSX | CI |
|---|---|---|
| Volatility (1Y, Annualized) | 40.16% | 26.82% |
| Beta (5Y) | 0.57 | 0.24 |
| Max Drawdown (5Y) | -61.55% | -32.10% |
| Avg. Volume (3M) | 19.73M | 1.55M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BSX | CI |
|---|---|---|
| Sharpe Ratio (1Y) | -1.50 | 0.36 |
| Sortino Ratio (1Y) | -1.80 | 0.54 |
Profitability
ROE (TTM)
Cigna (CI) at 15.65% sits in the top ROE quartile, while Boston Scientific (BSX) at 14.12% is closer to the peer norm — stronger capital efficiency for CI.
BSX
Health Care Equipment & Services industry group
14.12%
- Max
- 47.61%
- Q3
- 14.36%
- BSX
- 14.12%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
CI
Health Care Equipment & Services industry group
15.65%
- Max
- 47.61%
- CI
- 15.65%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Boston Scientific (BSX) at 16.62% retains a top-quartile share of revenue as profit, ahead of Cigna (CI) at 2.09%, which keeps about the industry-typical share.
BSX
Health Care Equipment & Services industry group
16.62%
- Max
- 29.35%
- BSX
- 16.62%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
CI
Health Care Equipment & Services industry group
2.09%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- CI
- 2.09%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Boston Scientific (BSX) at 19.05% operates in the top operating margin quartile, ahead of Cigna (CI) at 3.48%, which runs around its industry’s norm.
BSX
Health Care Equipment & Services industry group
19.05%
- Max
- 35.43%
- BSX
- 19.05%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
CI
Health Care Equipment & Services industry group
3.48%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- CI
- 3.48%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BSX | CI |
|---|---|---|
| ROE (TTM) | 14.12% | 15.65% |
| ROA (TTM) | 5.87% | 4.29% |
| Net Margin (TTM) | 16.62% | 2.09% |
| Operating Margin (TTM) | 19.05% | 3.48% |
| Gross Margin (TTM) | 67.98% | 9.09% |
Growth
Revenue Growth
Both Boston Scientific (BSX) at 19.87% and Cigna (CI) at 11.26% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Both Boston Scientific (BSX) at 55.20% and Cigna (CI) at 83.00% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.
Growth Metrics
| Metric | BSX | CI |
|---|---|---|
| Revenue Growth (YoY) | 19.87% | 11.26% |
| Revenue Growth (3Y CAGR) | 16.54% | 15.15% |
| EPS Growth (YoY) | 55.20% | 83.00% |
| EPS Growth (3Y CAGR) | 62.75% | 1.36% |
Financial Strength
Current Ratio (MRQ)
Both Boston Scientific (BSX) at 1.37 and Cigna (CI) at 0.84 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
BSX
Health Care Equipment & Services industry group
1.37
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- BSX
- 1.37
- Min
- 0.30
CI
Health Care Equipment & Services industry group
0.84
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- CI
- 0.84
- Min
- 0.30
Debt / Equity (MRQ)
Both Boston Scientific (BSX) at 0.46 and Cigna (CI) at 0.71 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
BSX
Health Care Equipment & Services industry group
0.46
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- BSX
- 0.46
- Q1
- 0.16
- Min
- 0.00
CI
Health Care Equipment & Services industry group
0.71
- Max
- 1.88
- Q3
- 0.91
- CI
- 0.71
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | BSX | CI |
|---|---|---|
| Current Ratio (MRQ) | 1.37 | 0.84 |
| Debt / Equity (MRQ) | 0.46 | 0.71 |
| Net Debt / EBITDA | 2.04 | 1.87 |
Dividends
Dividend Yield (TTM)
Boston Scientific (BSX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cigna (CI) reports a yield of 2.05%, ranking against industry peers normally.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
CI
Health Care Equipment & Services industry group
2.05%
- CI
- 2.05%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Boston Scientific (BSX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cigna (CI) reports a payout of 27.29%, ranking against industry peers normally.
BSX
Health Care Equipment & Services industry group
0.00%
- BSX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
CI
Health Care Equipment & Services industry group
27.29%
- CI
- 27.29%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BSX | CI |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 2.05% |
| Dividend Payout Ratio (TTM) | 0.00% | 27.29% |
Valuation
P/E Ratio (TTM)
Both Boston Scientific (BSX) at 18.04 and Cigna (CI) at 12.94 sit in the cheaper earnings-multiple quartile for P/E ratio, with the market paying less for a dollar of trailing earnings than it pays for typical peers.
BSX
Health Care Equipment & Services industry group
18.04
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- BSX
- 18.04
- Min
- 4.21
CI
Health Care Equipment & Services industry group
12.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- CI
- 12.94
- Min
- 4.21
P/S Ratio (TTM)
Cigna (CI) at 0.27 sits in the cheaper P/S ratio quartile while Boston Scientific (BSX) at 2.94 prices around its industry’s middle — CI costs less per dollar of sales, though read it alongside growth and margins.
BSX
Health Care Equipment & Services industry group
2.94
- Max
- 8.80
- Q3
- 4.32
- BSX
- 2.94
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
CI
Health Care Equipment & Services industry group
0.27
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- CI
- 0.27
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Boston Scientific (BSX) at 2.42 and Cigna (CI) at 1.79 are valued close to their industries’ norm against book — neither stands out from peers.
BSX
Health Care Equipment & Services industry group
2.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BSX
- 2.42
- Q1
- 1.73
- Min
- -1.31
CI
Health Care Equipment & Services industry group
1.79
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- CI
- 1.79
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | BSX | CI |
|---|---|---|
| P/E Ratio (TTM) | 18.04 | 12.94 |
| P/S Ratio (TTM) | 2.94 | 0.27 |
| P/B Ratio (MRQ) | 2.42 | 1.79 |
| Free Cash Flow Yield (TTM) | 4.02% | 10.59% |